Adagloxad simolenin Uses, Dosage, Side Effects and more
Adagloxad simolenin is under investigation in clinical trial NCT03562637 (Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC).
| Attribute | Details |
|---|---|
| Trade Name | Adagloxad simolenin |
| Generic | Adagloxad simolenin |
| Adagloxad simolenin Other Names | Adagloxad simolenin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
